The Quantellect read.As of Nov 19, 2026, 9 active firms cover Korro Bio, Inc: 9 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $15.00 to $30.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $20.75 sits 67% above the current $12.39. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.03 next quarter toward $-4.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Buy
Strong Buy00%
Buy9100%
Neutral00%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$20.75
+67.5% upside
Average target across 8 active firms as of Nov 19, 2026 vs $12.39 current
Highest Target$30.00
Average Target$20.75
Lowest Target$15.00
Detailed analyst forecasts for KRRO
Showing 1–9 of 9 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 9 of 9 active firms rate KRRO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
KRRO EPS & revenue forecast
EPS · NEXT QUARTER
$-1.03
Range $-1.25 – $-0.80 · 6 analysts · -39% YoY
Next period, 6 analysts expect Korro Bio, Inc. to earn $-1.03 a share (range $-1.25 – $-0.80), versus $-1.69 a year earlier. Full-year consensus is $-4.68, growing to $-4.25 the year after.
REVENUE · NEXT QUARTER
$100.0K
Range $0 – $500.0K · 6 analysts
Revenue is expected to reach $100.0K (range $0 – $500.0K). Full-year consensus is $979.4K, rising to $337.5K next year.
Top analysts covering Korro Bio, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KRRO.
#1
Luca Issi
RBC Capital · Rank #76
Neutral
$10.00-19.3% to target
Overall win rate
49%
+ Follow
#2
Keay Nakae
Chardan Capital · Rank #130
Buy
$15.00+21.1% to target
Overall win rate
41%
+ Follow
#3
Mitchell Kapoor
HC Wainwright & Co. · Rank #305
Buy
$15.00+21.1% to target
Overall win rate
33%
+ Follow
#4
Yasmeen Rahimi
Piper Sandler · Rank #339
Buy
$30.00+142.1% to target
Overall win rate
30%
+ Follow
#5
Andreas Argyrides
Oppenheimer · Rank #380
Buy
$90.00+626.4% to target
Overall win rate
41%
+ Follow
KRRO stock forecast FAQ
What is KRRO's average 12-month price target?+
The 8 active firms with a live target average $20.75 for Korro Bio, Inc. over the next 12 months, ranging from a $30.00 high to a $15.00 low, as of Nov 19, 2026.
Is KRRO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 9 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for KRRO?+
The Street-high target is $30.00 (Piper Sandler), and the Street-low is $15.00 (HC Wainwright & Co.). The average of all 8 active-firm targets is $20.75.
How many active Wall Street firms cover KRRO?+
9 active firms have a recognized rating on Korro Bio, Inc. as of Nov 19, 2026, and 8 active firms carry a live 12-month price target.
Who is the most accurate analyst covering KRRO?+
Among analysts who currently cover KRRO, Luca Issi of RBC Capital has the strongest overall Quantellect track record (Rank #76). Their current call is Neutral with a $10.00 target.
What is Korro Bio, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.03 per share (range $-1.25 – $-0.80) across 6 analysts. Full-year EPS is projected at $-4.68, rising to $-4.25 the following year.
How much revenue is Korro Bio, Inc. expected to report next quarter?+
Consensus revenue is $100.0K (range $0 – $500.0K). Full-year revenue is projected at $979.4K, growing to $337.5K next year.
Have analysts been upgrading or downgrading KRRO lately?+
As of Nov 19, 2026, 9 of 9 active firms rate KRRO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KRRO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.